March 20, 2023
News Summary: The Waters™ Alliance™ iS High Performance Liquid Chromatography (HPLC) System brings a new level of simplicity and instrument intelligence to QC analyses, helping laboratories eliminate up to 40% of common errors. Next-generation HPLC System pairs with Waters Empower™ Chromatography Software and eConnect™ HPLC Columns to help laboratories manage operational risk, mitigate disruptions, and [...]
Quantabio Adds Powerful Bead Booster Chemistry to Ultra-Fast sparQ RNA-Seq HMR Kit
March 20, 2023
New optimizations increase yields up to 5x, accelerate workflows by more than 35% and reduce sample preparation costs by up to 30% BEVERLY, Mass. – Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced a new optimized Bead Booster chemistry [...]
Dirk Bontridder Appointed as CEO of New PerkinElmer Business Acquired by New Mountain Capital
March 20, 2023
NEW YORK -- The new PerkinElmer business acquired by New Mountain Capital announced today the appointment of Dirk Bontridder as Chief Executive Officer effective March 13, 2023. The newly independent company includes the flagship OneSource laboratory and field services as well as a portfolio of atomic spectroscopy, molecular spectroscopy, and chromatography instruments, consumables and reagents [...]
Akoya Biosciences Announces Leadership Transition
March 20, 2023
Joe Driscoll to Retire After More than Four Successful Years as Chief Financial Officer Johnny Ek Appointed as new Chief Financial Officer MARLBOROUGH, Mass. -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Chief Financial Officer Joe Driscoll is retiring from his position, effective March 20, 2023. Johnny Ek has [...]
Introducing the all new Image-Pro® version 11!
March 20, 2023
Media Cybernetics is proud to release the all new Image-Pro® v11, our most advanced scientific image analysis platform for industrial and life science industries. This latest version goes beyond its predecessors, offering innovative capabilities and seamlessly connecting every aspect of the imaging workflow with a single solution. “Image-Pro version 11 is a significant leap forward for [...]
March 20, 2023
Oxford Nanopore’s devices with 4bases kits will enable decentralised, flexible scalability with a significant decrease in turnaround time for clinical researchers in Italy and Switzerland, with a first target of same-day BRCA1 and BRCA2 analysis. Oxford Nanopore Technologies plc (Oxford Nanopore) and 4bases, a Switzerland-based company, specialising in kits for sequencing and bioinformatic tools, today announce [...]
March 20, 2023
BOSTON -- Stilla Technologies, the multiplex digital PCR company, has recently introduced the Ruby Chip, the industry’s first ‘load-and-go’ consumable for digital PCR, optimized for its naica® system. The naica® system, which now supports 21 CFR Part 11 regulatory compliance, is part of a fully-automated sample-to-results workflow – the first of its kind for digital PCR. This platform [...]
March 20, 2023
News Summary: New Battery Cycler Microcalorimeter Solution collects up to six times more data than other commercially available calorimeters.i Integrated real-time data analysis accelerates validation of battery safety, quality, and performance testing by up to 75%.ii Up to 12 batteries can be tested simultaneously for charge-discharge and thermal testing to design experiments in multiple configurations. [...]
Scientist.com Expands Disease Model Platform with Thousands of Additional Models from Top CROs
March 20, 2023
Researchers can now access over 8,000 patient-derived xenografts (PDX), cell-derived xenografts (CDX), organoids and cell lines from Scientist.com’s AI-powered Disease Model Finder SAN DIEGO -- Scientist.com, the premier R&D marketplace for the biopharmaceutical industry, announced today that it has partnered with leading contract research organizations (CROs), including Crown Bioscience, Imagen Therapeutics and Experimental Pharmacology & Oncology Berlin-Buch (EPO) to boost [...]
Illumina Underscores Commitment to Shareholder Value and Responds to Carl Icahn’s Statements
March 20, 2023
Illumina's plan will maximize shareholder value Illumina is engaged with regulators to define GRAIL's path forward as expeditiously as possible Icahn's director nominees do not add value to the Board and will damage Illumina's core business SAN DIEGO -- Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued the following response [...]

